Dr. Tamamyan is a Professor and the Chairman of the Department of Hematology and Pediatric Oncology at Yerevan State Medical University (YSMU), President of the International Society of Pediatric Oncology Asia Continental Branch (SIOP Asia), President of the Pediatric Oncology East and Mediterranean (POEM) Group, CEO of the Immune Oncology Research Institute, Co-Chair of St. Jude EURO Regional Advisory Committee, Chairman of the Board and Co-founder of the Institute of Cancer and Crisis, and the Editor-in-Chief and Co-Founder of OncoDaily.

Dr. Tamamyan is also the adviser to the Rector of YSMU. He is the ambassador of the Society of Hematologic Oncology, member of the ASCO International Committee’s Steering Group and Grants Selection Committee, member of the SIOP Essential Medications Working Group, International Scientific Advisory Board Member of the Sharing Progress in Cancer Care (SPCC), Expert Council Member of the ACT for Children, Co-founder of the Armenian Association of Hematology and Oncology, a Co-founder and a Board Member of the City of Smile Foundation, the largest cancer charity in Armenia.

MD and PhD degrees, he received from YSMU and MSc from the University of Ulm (Germany). He completed postdoc in leukemia at the University of Texas MD Anderson Cancer Center (USA), visiting fellowships at China Medical University Hospital (Taiwan) and St. Anna Children’s Hospital (Austria), was a medical research fellow at the Headquarters of the European Organization for Research and Treatment of Cancer (Belgium), visiting scientist at Dana-Farber/Boston Children’s Cancer and Blood Disorders Center (USA), completed High-Impact Cancer Research postgraduate program at the Harvard Medical School (USA), Global Health Delivery Intensive Course at the Harvard School of Public Health (USA), and Global Health Diplomacy Executive Course at the University of Toronto (Canada). He is a recipient of numerous awards and distinctions, among them the ASCO IDEA (2013) and LIFe (2014) Awards, 40 Under 40 in Cancer Award (2022), he was recognized as a Young Leader of the International Agency for Cancer Research (2016) and Union for International Cancer Control (2016), and selected for the ASCO Leadership Development Program (2022).